CVS HEALTH Corp Earnings Per Share Disclosure
| In millions, except per share amounts | 2025 | 2024 | 2023 | ||||||||||||||
| Numerator for earnings per share calculation: | |||||||||||||||||
| Net income attributable to CVS Health | $ | 1,768 | $ | 4,614 | $ | 8,344 | |||||||||||
| Denominator for earnings per share calculation: | |||||||||||||||||
| Weighted average shares, basic | 1,267 | 1,259 | 1,285 | ||||||||||||||
| Restricted stock units and performance stock units | 3 | 2 | 3 | ||||||||||||||
| Stock options and SARs | 1 | 1 | 2 | ||||||||||||||
| Weighted average shares, diluted | 1,271 | 1,262 | 1,290 | ||||||||||||||
| Earnings per share: | |||||||||||||||||
| Basic | $ | 1.40 | $ | 3.67 | $ | 6.49 | |||||||||||
| Diluted | $ | 1.39 | $ | 3.66 | $ | 6.47 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 10, 2026 | Showing above |
| 2024 | Feb 12, 2025 | |
| 2023 | Feb 7, 2024 | |
| 2022 | Feb 8, 2023 | |
| 2021 | Feb 9, 2022 | |
| 2020 | Feb 16, 2021 | |
| 2017 | Feb 14, 2018 | |
| 2016 | Feb 9, 2017 | |
| 2015 | Feb 9, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.